Article in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Barbara BirkayaCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.
Ahana ByneCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.
Sumaiya IrfanCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.
Joseph GallagherCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.
Dominic GranatoCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.
Hayat KharmoudCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.
Andrea Blake BrothersCollege Dean's Office, American University, Washington, DC 20016, USA.ORCID 0009-0003-3943-0403
Elsa RonzierBiomedical Research Laboratory, Institute for Biohealth Innovation, George Mason University, 10650 Pyramid Place, Manassas, VA 20110, USA.ORCID 0000-0003-1008-4271
Amanda Haymond StillCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.
Weidong ZhouCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.ORCID 0000-0001-8802-3597
Robert K ErnstDepartment of Microbial Pathogenesis, University of Maryland School of Dentistry, Baltimore, MD 21021, USA.ORCID 0000-0001-5016-8694
Hope McIntyreLyme Hope, LLC, Mount Airy, MD 21771, USA.
Ashley Michelle GroshongLaboratory of Bacteriology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.ORCID 0000-0002-6674-7532
Lance A LiottaCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.ORCID 0000-0001-5155-7907
Alessandra LuchiniCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.ORCID 0000-0003-1599-0214
Funding
Commonwealth Health Research Board #247-09-24USAMRAA HT94252410629
6 · The paper itself
Abstract
The cause of chronic neurological effects associated with Lyme disease (LD) remains unclear. We propose that bacterial extracellular vesicles (BEVs) released by
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.